Overview
Join Us in Changing Lives
AtOXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respectful.
We’re currently recruiting for aAseptic Filling Biotechnologist to join our Manufacturing team. In this role, you willbe responsible for performing functions related to production and GMP manufacturing operations, playing a key part in advancing our mission and making a real difference.
Your responsibilities in this role would be:
* Contributing to housekeeping including cleaning, sanitisation and sterilisation of equipment and components
* Performing all manufacturing operations including but not limited to component transfer and preparation, equipment and area preparation
* Maintaining QMS documentation, keeping accurate records, following instructions and complying with company policies
* Supporting troubleshooting activities and assisting with continuous improvement initiatives
* Being accountable as part of a team of Aseptic Filling Biotechnologists working on shift pattern to successfully fill, inspect, label and pack Vector Product
* Investigating quality incidents, deviations and improving procedures
We are Looking For:
* Cleanroom experience or good understanding of GMP and GCP preferred
* Willingness to follow GMP PPE requirements during the working shift
* BSc Life Sciences or equivalent or alternatively some previous experience of working within a biological or chemical GMP manufacturing environment
* Flexibility to work shift patterns inclusive of weekends
About Us:
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
Why Join Us?
* Competitive total reward packages
* Wellbeing programs that support your mental and physical health
* Career development opportunities to help you grow and thrive
* Supportive, inclusive, and collaborative culture
* State-of-the-art labs and manufacturing facilities
* A company that lives its values:Responsible, Responsive, Resilient, Respect
We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.
Ready to Make a Difference?
Collaborate. Contribute. Change lives.
We offer:
* Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica\'s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
#J-18808-Ljbffr